Skip to search formSkip to main contentSkip to account menu

allitinib

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

AST 1306

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
PO-504 The impact of KRAS mutations on the cytotoxic effects of afatinib and allitinib in non-small cell lung cancer cell line
Introduction EGFR alterations (overexpression and mutations) are frequent events in non-small cell lung cancer (NSCLC). In the… 
2017
2017
AKT can modulate the in vitro response of HNSCC cells to irreversible EGFR inhibitors
Epidermal growth factor receptor (EGFR) is overexpressed in up to 90% of head and neck squamous cell carcinoma (HNSCC) tumors… 
Review
2016
Review
2016
[Metabolic research of domestically developed small molecule tyrosine kinase inhibitors].
Drug metabolism research plays an essential role in drug discovery and development. Great efforts have been made domestically to… 
2016
2016
Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker
The epidermal growth factor receptor (EGFR) is a member of the HER family of growth factors that activates several intracellular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)